Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.
Hi, what are you looking for?
Jewish Business News
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
The US biotech company currently markets its products in Israel through NewPharm.
Business
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
Business
"Reuters" said the settlement would be the largest ever paid over allegations of delaying generic drugs.
Business
Kenalog® Spray annual sales were approximately $16 million according to IMS Health.
Business
Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA), the world’s fifth largest generic pharmaceutical company and India’s top pharmaceutical company, and the Technion, Israel’s institute...
Business
To be blunt, finding a cure for pancreatic cancer would be difficult to come up with and the expense too high to justify the...
Business
It's tictoc, tictoc, for Teva.